关于我们
Mission We harness the power of molecular microbiology to develop diagnostic solutions that will optimize the treatment of life-threatening, drug resistant infections. We seek to dramatically transform patient care to guide antibiotic therapy selection and help improve antibiotic stewardship. About Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious disease. Our innovative approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels to address the global threat of antimicrobial resistance (AMR), improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). Together we improve patient care and fight AMR through cutting edge molecular microbiology.
- 网站
-
https://www.opgen.com
OpGen, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Rockville，Maryland
- 类型
- 上市公司
- 创立
- 2002
- 领域
- Antibiotic Resistance Testing、Healthcare Associated Infection Surveillance and Epidemiology、Clinical Services Laboratory、DNA Testing、Strain Typing、Bioinformatics、Molecular Diagnostics和Comparative Genomics